Is BIOL a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

593 people get BIOL articles and Market Currents by email alert.

Get email alerts on BIOL »

HEADLINES:

BIOLASE Declares Stock Dividend for 2013 Second Quarter

Marketwire (Tue, 9:00AM)
NewTom BIOLASE VG3 Panoramic Oral X-Ray System Receives FDA Clearance

Marketwire (Thu, 9:10AM)
BIOLASE Awarded Two New Patents

Marketwire (Wed, 9:00AM)
BIOLASE Receives FDA Clearance for Orthopedic and Podiatric WaterLase iPlus

Marketwire (May 8, 2013)
BIOLASE's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Wed, May 8
BIOLASE Enters Affiliation Agreement With Sun Dental Laboratories, LLC

Marketwire (May 7, 2013)
USPTO Rejects All Claims Subject to Reexamination in the CAO Group's Patent Action Against BIOLASE

Marketwire (May 7, 2013)
Comerica Increases Available Borrowings Under Amended Credit Facilities

Marketwire (May 7, 2013)
BIOLASE Reports 2013 First Quarter Results

Marketwire (May 7, 2013)
Wall Street Journal Article Features BIOLASE's Virtually Painless WaterLase Technology

Marketwire (May 1, 2013)
BIOLASE to Host First Quarter 2013 Results Conference Call and Webcast on May 7th at 4:30 P.M. EDT

Marketwire (Apr 30, 2013)
BIOLASE Enters Into Agreement for Lambda S.p.A. to Pay Royalties

Marketwire (Apr 17, 2013)
BIOLASE Awarded New Patent for Non-Contact Handpiece for Tissue Cutting

Marketwire (Apr 16, 2013)
BIOLASE Receives FDA Clearance for the EPIC 10S Soft Tissue Diode Laser for a Broad Spectrum of Medical Procedures

Marketwire (Apr 11, 2013)
BIOLASE Engages Porter, LeVay & Rose, Inc. for Investor Relations

Marketwire (Apr 11, 2013)
BIOLASE Joins OSAP in Fight for Safe and Infection-Free Oral Healthcare

Marketwire (Apr 4, 2013)
3 Biotech Stars Ready To Shine
Craig Keolanui • Thu, Mar 28 • 2 Comments
BIOLASE Holds Annual Distributor Meeting at 35th IDS International Dental Show in Cologne, Germany

Marketwire (Mar 13, 2013)
BIOLASE Inc. CEO Discusses Q4 2012 Results - Earnings Call Transcript
Thu, Mar 7
BIOLASE Reports 2012 Fourth Quarter, Year-End Results

Marketwire (Mar 6, 2013)

To learn more about Seeking Alpha Pro, click here.

Biolase A Strong Value Buy In The Biotech Space
EnhydrisPECorp • Fri, Feb 1 • 8 Comments
Why I Picked Up BioLase Technology Heading Into The Weekend
Bret Jensen • Fri, Mar 16, 2012 • 11 Comments
BioLase Powers Ahead on New Product Launches
Proactive Investor • Thu, Apr 7, 2011 • 1 Comment
Is Biolase On the Mend?
Douglas Cress • Sun, Jul 13, 2008 • 1 Comment
BioLase: Stock Plunges On Dismal 3Q Results
Herb Greenberg • Wed, Nov 7, 2007
BioLase: Announcement of Q1 Losses Smells Fishy
Herb Greenberg • Thu, Apr 12, 2007

3 Biotech Stars Ready To Shine
Craig Keolanui • Thu, Mar 28 • 2 Comments
4 Small Caps Seeing Positive Reversals
Leopold Epstein • Mon, Feb 18 • 2 Comments
5 Healthcare Companies With Insider Buying Filed On August 22 - 23
Markus Aarnio • Sat, Aug 25, 2012 • 2 Comments
3 Micro-Cap Value Stocks That Could Double
StreetAuthority • Tue, Mar 13, 2012
18 Oversold Stocks With Bullish Short Trends
Kapitall • Tue, Dec 6, 2011 • 3 Comments
20 Healthcare Stocks With Strong Sales Trends
Kapitall • Thu, Dec 1, 2011
5 Small Stocks With Home-Run Potential
StreetAuthority • Wed, Nov 16, 2011
Find Upside In These Dental Appliance Makers
Neoclassical Economist • Mon, Oct 31, 2011 • 2 Comments
Monday's (July 25) Gainers and What's in Store for These Companies
Brian Nichols • Tue, Jul 26, 2011
Top Buy Ideas Based on Last Week's Biggest Losers
GuruFundPicks • Tue, Jul 19, 2011 • 1 Comment
5 Stocks Posting Big Losses Last Week
Alex Shadunsky • Mon, Jul 18, 2011
5 Stocks Down on Wednesday
Alex Shadunsky • Thu, Jul 14, 2011
The Best Performing U.S. Stocks at the Halfway Point
Bespoke Investment Group • Fri, Jul 1, 2011
50 Best Performing Stocks Year to Date
Bespoke Investment Group • Mon, Jun 27, 2011 • 1 Comment
Analyzing Wednesday's News Movers: VirnetX, Biolase and Finisar
GuruFundPicks • Thu, Apr 7, 2011 • 1 Comment
3 Small Stocks Worth a Look
StreetAuthority • Wed, Jan 19, 2011 • 9 Comments
Biolase CEO Draws the Company Out of an Abysmal Year
Douglas Cress • Tue, Feb 12, 2008
Stocks With the Largest Intraday High-Low Ranges
Bespoke Investment Group • Thu, Jun 14, 2007
Why Does Proctor & Gamble Need Dental Laser Technology?
H.S. Ayoub • Fri, Jan 26, 2007
Dental Industry Investing: The Future Looks Bright
H.S. Ayoub • Mon, Nov 13, 2006 • 3 Comments

BIOLASE's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Wed, May 8
BIOLASE Inc. CEO Discusses Q4 2012 Results - Earnings Call Transcript
Thu, Mar 7
BIOLASE's Management Presents at Lazard Capital Markets 9th Annual Healthcare Conference (Transcript)
Tue, Nov 13, 2012
BIOLASE' CEO Discusses Q3 2012 Results - Earnings Call Transcript
Tue, Nov 6, 2012
Biolase's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Thu, Aug 9, 2012
BIOLASE Technology, Inc. Q4 2007 Earning Call Transcript
Tue, Mar 11, 2008

BIOLASE Declares Stock Dividend for 2013 Second Quarter

Marketwire (Tue, 9:00AM)
NewTom BIOLASE VG3 Panoramic Oral X-Ray System Receives FDA Clearance

Marketwire (Thu, 9:10AM)
BIOLASE Awarded Two New Patents

Marketwire (Wed, 9:00AM)
BIOLASE Receives FDA Clearance for Orthopedic and Podiatric WaterLase iPlus

Marketwire (May 8, 2013)
BIOLASE Enters Affiliation Agreement With Sun Dental Laboratories, LLC

Marketwire (May 7, 2013)
USPTO Rejects All Claims Subject to Reexamination in the CAO Group's Patent Action Against BIOLASE

Marketwire (May 7, 2013)
Comerica Increases Available Borrowings Under Amended Credit Facilities

Marketwire (May 7, 2013)
BIOLASE Reports 2013 First Quarter Results

Marketwire (May 7, 2013)
Wall Street Journal Article Features BIOLASE's Virtually Painless WaterLase Technology

Marketwire (May 1, 2013)
BIOLASE to Host First Quarter 2013 Results Conference Call and Webcast on May 7th at 4:30 P.M. EDT

Marketwire (Apr 30, 2013)
BIOLASE Enters Into Agreement for Lambda S.p.A. to Pay Royalties

Marketwire (Apr 17, 2013)
BIOLASE Awarded New Patent for Non-Contact Handpiece for Tissue Cutting

Marketwire (Apr 16, 2013)
BIOLASE Receives FDA Clearance for the EPIC 10S Soft Tissue Diode Laser for a Broad Spectrum of Medical Procedures

Marketwire (Apr 11, 2013)
BIOLASE Engages Porter, LeVay & Rose, Inc. for Investor Relations

Marketwire (Apr 11, 2013)
BIOLASE Joins OSAP in Fight for Safe and Infection-Free Oral Healthcare

Marketwire (Apr 4, 2013)
BIOLASE Holds Annual Distributor Meeting at 35th IDS International Dental Show in Cologne, Germany

Marketwire (Mar 13, 2013)
BIOLASE Reports 2012 Fourth Quarter, Year-End Results

Marketwire (Mar 6, 2013)
BIOLASE CEO to Continue at Symbolic Annual Cash Salary of $1.00

Marketwire (Mar 6, 2013)
BIOLASE Declares Stock Dividend for 2013 First Quarter

Marketwire (Feb 28, 2013)
BIOLASE Launches Soft-Tissue Diode Laser for Veterinary Applications

Marketwire (Feb 26, 2013)

BIOL vs. ETF Alternatives

Company Description

BIOLASE, Inc. develops, manufactures, and markets lasers systems for dental and medical applications and procedures in the United States and internationally. It provides Waterlase system for cutting hard tissues and soft tissues. The company also offers Diode laser systems for use in soft tissue... More

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Tuesday, May 7, 4:28 PM Biolase (BIOL): Q1 EPS of -$0.06 misses by $0.05. Revenue of $14.6M (+19% Y/Y) beats by $0.12M. Shares -2.5% AH. (PR) Comment! [Earnings, Breaking News, Healthcare, On the Move]
Tuesday, May 7, 12:10 AM Notable earnings after Tuesday’s close: ANDE, ARAY, AWK, AXLL, BIO, BIOL, BMC, BWC, CA, CDXS, CHRW, CODI, DGI, DGIT, DIS, DVA, EA, ENPH, EXEL, GA, GPOR, HTA, IAG, JAZZ, KGC, LYV, MAKO, MCEP, MCK, MDLZ, MITK, MRO, MYGN, NVTL, OAS, OCLR, OHI, ONXX, ORA, PRI, RBCN, SD, SGEN, SYMC, SYNC, TRIP, TWO, URS, VCLK, WBMD, WFM, WMB, WPZ, WTI, Z 1 Comment [Earnings]
Monday, May 6, 5:35 PM Notable earnings after Tuesday’s close: ANDE, ARAY, AWK, AXLL, BIO, BIOL, BMC, BWC, CA, CDXS, CHRW, CODI, DGI, DGIT, DIS, DVA, EA, ENPH, EXEL, GTEK, GA, GPOR, IAG, JAZZ, KGC, LYV, MAKO, MCEP, MCK, MDLZ, MITK, MRO, MYGN, NVTL, OAS, OCLR, OHI, ONXX, ORA, PRI, RBCN, SD, SGEN, SYMC, SYNC, TRIP, TWO, URS, VCLK, WBMD, WFM, WMB, WPZ, WTI, Z 1 Comment [Earnings]
Monday, April 29, 12:56 PM Midday top 10 gainers: OSH +43%. WRLS +31%. CPTS + 19%. MDSO +20%. GALT +19%. LEDS +18%. FXEN +17%. OSBC +14%. PRGN +12%. CCH +12%.
Midday top 10 losers: LAS -31%. NTE -28%. HGSH -20%. GWAY -19%. LXRX -18%. FVE -15%. AUXL -11%. MLP -10%. CETV -10%. BIOL -10%. Comment! [On the Move]
Thursday, April 11, 2:09 PM Biolase (BIOL +13.3%) posts outsized gains after the FDA approves its EPIC 10S" soft tissue diode laser for surgical use in "over 80 different indications in 19 medical markets." CEO Federico Pignatelli says the clearance gives the company "the ability to leverage [the instrument] across a wide range of multi-billion dollar medical markets." SA contributor Craig Keolanui called the stock a "rising star" late last month. Comment! [Healthcare, On the Move]
Thursday, April 11, 12:49 PM Midday top 10 gainers: ACAD +55%. RNIN +26%. RAD +18%. ZUMZ +15%. MEA +13%. BIOL +12%. MGT +12%. PBTH +12%. MPAC +11%. TVL +11%.
Midday top 10 losers: LEDS -17%. FTNT -14%. ROYL -14%. NTIC -16%. HXM -11%. CREG -11%. PRMW -10%. GNVC -10%. SGYP -10%. OCZ -10%. Comment! [On the Move]
Wednesday, March 6, 4:47 PM Biolase (BIOL): Q4 EPS of $0.05 beats by $0.05. Revenue of $19.1M (+45% Y/Y) beats by $1.1M. Shares +5.9% AH. (PR) Comment! [Earnings, Breaking News, Healthcare]
Monday, February 11, 12:45 PM Midday top 10 gainers: OBT +37%. ZN +22%. MLNK +17%. OESX +14%. MDCI +13%. MCBC +13%. UNXL +11%. XRSC +11%. DMND +11%. IEP +11%.
Midday top 10 losers: NVO -15%. GMXR -14%. DSKX -11%. ESTE -10%. AMBO -10%. CRVP -9%. ALCS -8%. GALT -8%. HEK -8%. BIOL -8%. Comment! [On the Move]
Thursday, February 7, 12:18 PM The hits keep coming for Biolase (BIOL +6%) as the USPTO issues it a new patent covering the use of its laser technologies for treating a broad range of eye conditions, including presbyopia, glaucoma, retinal disorders, and cataracts. The patent supports existing ophthalmic patents previously granted by expanding the application of the laser to include the architecture and techniques for treating an ocular or related tissue site with a measuring device capable of determining the thickness of the tissue. Comment! [Healthcare, On the Move]
Thursday, February 7, 9:14 AM Premarket gainers: OXGN +31%. SUTR +29%. DV +18%. BIOL +9%. AAP +9%. ORLY +9%. APPY +7%. LF +6%.
Losers: AKAM -18%. TQNT -11%. ARAY -9%. ANN -9%. GMCR -9%. NXST -6%. BBEP -6%. MWW -6%. BG -5%. ATML -5%. Comment! [On the Move]
Wednesday, February 6, 12:45 PM Midday top 10 gainers: IGOI +28%. BIOL +27%. JAXB +22%. GDP +21%. CACH +20%. KFRC +19%. SFLY +20%. POWL +14%. MFR +14%. MUSA +13%.
Midday top 10 losers: VOCS -17%. CVU -14%. CALX -13%. OPAY -10%. AERL -10%. CHRW -10%. URRE -10%. SSY -9%. WXS -9%. ELN -8%. Comment! [On the Move]
Wednesday, February 6, 11:40 AM Biolase (BIOL +28%) soars after the FDA approves it's Diolase 10 diode soft tissue laser for a broad spectrum of over 80 procedures in 18 different medical markets, including pulmonary and vascular surgery. The company's diode lasers are primarily used in dentistry for surgical soft tissue procedures as an alternative to invasive and traumatic conventional devices, such as the high-speed drill or scalpel, and the approval significantly expands its potential for new markets. Comment! [Healthcare, On the Move]
Monday, January 14, 12:45 PM Midday top 10 gainers: AZK +33%. NEWL +25%. CBAN +20%. THTI +17%. ADEP +17%. BIOL +15%. HALO +14%. CXPO +11%. FNP +10%. CTC +10%.
Midday top 10 Losers: TELK -22%. NTE -12%. APT -11%. EDMC -11%. MXT -9%. HGG -9%. SPRO -9%. CRUS -8%. CEDC -8%. CBMX -7%. Comment! [On the Move]
Monday, January 7, 12:45 PM Midday top 10 gainers: PPHM +67%. MDCI +28%. DLGC +24%. EPOC +22%. BIOL +21%. RFIL +21%. BITA +16%. PRGN +15%. CHRM +15%. CBMX +15%.
Midday top 10 Losers: HILL -20%. ESI -17%. STP -13%. SWSH -11%. PGRX -11%. PSEM -11%. IHT -11%. CDXS -10%. ACHN -10%. NED -9%. Comment! [On the Move]
Monday, January 7, 11:47 AM Shares of Biolase (BIOL +16%) pops after posting upbeat Q4 guidance, now expecting revenues above $18M, primarily due to the increased demand for its flagship WaterLase iPlus and its new EPIC 10 soft tissue diode laser. The company also noted that it's expecting a substantial acceleration in the adoption of lasers over the next few years. Analysts are looking for $17.9M in revenues, putting the company's projection in-line to just slightly ahead of estimates. Comment! [Healthcare, Earnings, On the Move]
Wednesday, October 3, 2012, 1:00 PM Biolase (BIOL +36%) shares are soaring after the company received 510(k) clearance from the FDA for its EPIC 10 diode soft tissue laser, and began immediately offering the device for sale in the U.S. The company also received CE Mark approval for the laser in the European Union and began commercial sales there, as well as in Asian and Latin American countries that also recognize the CE Mark, during the final few days of its Q3. Comment! [Healthcare, On the Move, Global & FX]

jjmclaughlin21
7/11/12 This purchase BIOL by BlackRock Inc. is the 5th large block of stock this year.
7/12/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

jjmclaughlin21
7/11/12 BIOL. BlackRock Inc filed SC 13 G/A to purchase 837,000 shares =2.7 %. What do they know, that we don't.
7/12/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

jjmclaughlin21
06/26/2012 Brecken Captial LLC. files 13 G with SEC. +5.0 % acquisition, 2,997,500 shares 9.16 %. Watch for a volume move. BIOL
6/26/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Ryan Mallory
1/31 Video Watchlist GTXI SBSA BORN COCO LCC ZLC END FBN RNWK BIOL RPTP SIMO CDY bit.ly/yYz5od
1/31/12
Reply (2)

• !Report Abuse
View all 2 replies
Luckydad: link not working, try again.
1/31/12
• !Report Abuse
Ryan Mallory: Sorry about that - try this: http://bit.ly/A1U1WL
2/1/12
• !Report Abuse
Add a reply...

140 characters

greenbackers
BIOL exceptional erngs today..keep an eye on for potential momentum extending tomorw...2.77 4:00PM EST Change: 1.10 (65.87%
1/20/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

Ryan Mallory
1/31 Video Watchlist GTXI SBSA BORN COCO LCC ZLC END FBN RNWK BIOL RPTP SIMO CDY bit.ly/yYz5od
1/31/12
Reply (2)

• !Report Abuse
View all 2 replies
Luckydad: link not working, try again.
1/31/12
• !Report Abuse
Ryan Mallory: Sorry about that - try this: http://bit.ly/A1U1WL
2/1/12
• !Report Abuse
Add a reply...

140 characters

BIOL Biolase, Inc.

BIOL

Biolase, Inc.